Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis

INTRODUCTION: Heart transplantation is the best treatment for end-stage dilated cardiomyopathy (DCM). Left ventricular assist device (LVAD) support is becoming more prevalent and may delay heart transplantation. Gene expression of the left ventricular myocardium usually changes following LVAD implan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Ying, Cao, Hao, Peng, Yuan-Yi, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063844/
https://www.ncbi.nlm.nih.gov/pubmed/37008310
http://dx.doi.org/10.3389/fcvm.2023.1013057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063844/
https://www.ncbi.nlm.nih.gov/pubmed/37008310
http://dx.doi.org/10.3389/fcvm.2023.1013057

Ejemplares similares